Lv1
90 积分 2025-09-23 加入
Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy
2个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
2个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
2个月前
已完结
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics
4个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
4个月前
已完结
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
